States with the lowest number of high school and college graduates also have the highest percentage of obese citizens. This ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

Studies have revealed that obesity and eating disorders disrupt the brain's normal response to food entering the stomach and ...

Congress has been considering bipartisan solutions to help address the growing obesity problem for over a decade now.

Two maps show the U.S.' health crisis hotspots, with rates of obesity and related diseases such as heart disease and diabetes ...

The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

Sometimes hyped as miracle drugs, even whispered about as elixirs, semaglutide and brand-name variants such as Ozempic and Wegovy are increasingly being taken against obesity and diabetes.But ...

Popular weight-loss drugs like Wegovy or Ozempic would be covered by Medicare or Medicaid under a newly-proposed rule by the ...

Obesity experts say that roughly 20% of patients — as many as 1 in 5 — may not see robust results with the new medications.

U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...

The Biden administration plans to require Medicare and Medicaid to offer coverage of weight loss medications for patients ...